Impaired GLP-1 secretion is a component of impaired GLP-1/GLP-1R system in patients with NAFLD, additional to a proposed GLP-1 resistance at the tissue level. This evidence concerns the gene GCG and metabolic dysfunction-associated steatotic liver disease.